盈康生命 (300143.SZ) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	2.0B	1.9B	1.6B	1.5B	1.2B
Cost of Revenue	1.4B	1.4B	1.2B	1.1B	849.5M
Gross Profit	524.8M	510.9M	403.3M	415.9M	306.8M
Operating Expenses
R&D Expense	53.4M	49.2M	54.5M	52.2M	28.0M
SG&A Expense	—	—	—	—	—
General & Admin Expense	196.1M	188.7M	155.4M	148.1M	136.9M
Selling & Marketing Expense	50.2M	46.8M	53.0M	58.8M	27.6M
Other Expenses	—	—	—	—	—
Total Operating Expenses	323.9M	301.9M	267.5M	264.5M	196.1M
Cost and Expenses	1.8B	1.7B	1.4B	1.3B	1.0B
Operating Income (EBIT)	164.3M	163.6M	128.0M	142.0M	(554.9M)
Non-Operating
Interest Income	—	—	—	—	—
Interest Expense	—	—	—	—	—
Net Interest Income	—	—	—	—	—
Other Non-Op Income/Expense	—	—	—	—	—
Non-Operating Income (excl Interest)	—	—	—	—	—
EBT (Pre-Tax Income)	152.9M	151.6M	149.3M	131.5M	(565.2M)
Income Tax Expense	64.1M	64.3M	33.3M	32.3M	30.6M
Bottom Line
Net Income	64.3M	68.5M	115.4M	100.4M	(595.9M)
Earnings from Cont. Ops	88.8M	87.4M	116.0M	99.2M	(595.8M)
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	64.3M	68.5M	115.4M	100.4M	(595.9M)
Per Share
Basic EPS	CN¥0.09	CN¥0.09	CN¥0.18	CN¥0.16	(CN¥1.01)
Diluted EPS	CN¥0.09	CN¥0.09	CN¥0.18	CN¥0.16	(CN¥1.01)
Revenue Per Share	CN¥2.65	CN¥2.48	CN¥2.43	CN¥2.34	CN¥1.96
Shares
Basic Shares Outstanding	744.4M	761.6M	641.2M	627.7M	590.0M
Diluted Shares Outstanding	744.4M	761.6M	641.2M	627.7M	590.0M
Profitability Metrics
EBITDA	—	249.2M	206.2M	209.5M	(503.9M)
D&A	—	85.6M	78.2M	67.5M	51.0M
EBIT	—	—	—	—	—

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026